A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration
Open Access
- 16 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 19 (10), 1930-1938
- https://doi.org/10.1093/hmg/ddq068
Abstract
Hyperphosphorylation of the microtubule associated protein tau is detected in the brains of individuals with a range of neurodegenerative diseases including Alzheimer's disease (AD). An imbalance in phosphorylation and/or dephosphorylation of tau at disease-related sites has been suggested to initiate the abnormal metabolism and toxicity of tau in disease pathogenesis. However, the mechanisms underlying abnormal phosphorylation of tau in AD are not fully understood. Here, we show that the DNA damage-activated Checkpoint kinase 2 (Chk2) is a novel tau kinase and enhances tau toxicity in a transgenic Drosophila model. Overexpression of Drosophila Chk2 increases tau phosphorylation at Ser262 and enhances tau-induced neurodegeneration in transgenic flies expressing human tau. The non-phosphorylatable Ser262Ala mutation abolishes Chk2-induced enhancement of tau toxicity, suggesting that the Ser262 phosphorylation site is involved in the enhancement of tau toxicity by Chk2. In vitro kinase assays revealed that human Chk2 and a closely related checkpoint kinase 1 (Chk1) directly phosphorylate human tau at Ser262. We also demonstrate that Drosophila Chk2 does not modulate the activity of the fly homolog of microtubule affinity regulating kinase, which has been shown to be a physiological tau Ser262 kinase. Since accumulation of DNA damage has been detected in the brains of AD patients, our results suggest that the DNA damage-activated kinases Chk1 and Chk2 may be involved in tau phosphorylation and toxicity in the pathogenesis of AD.Keywords
This publication has 82 references indexed in Scilit:
- Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathiesNature Reviews Drug Discovery, 2009
- Taking the time to make important decisions: The checkpoint effector kinases Chk1 and Chk2 and the DNA damage responseDNA Repair, 2009
- Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2Current Opinion in Cell Biology, 2009
- Dissociation of tau toxicity and phosphorylation: role of GSK-3β, MARK and Cdk5 in a Drosophila modelHuman Molecular Genetics, 2008
- Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brainFree Radical Biology & Medicine, 2008
- Tau Phosphorylation Sites Work in Concert to Promote Neurotoxicity In VivoMolecular Biology of the Cell, 2007
- Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's diseaseNucleic Acids Research, 2007
- Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairmentNucleic Acids Research, 2007
- Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic miceThe EMBO Journal, 2007
- Connecting cell-cycle activation to neurodegeneration in DrosophilaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007